This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Erber Aktiengesellschaft. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Corinna Kern: Innovator in Toxin-Cleaving Polypeptide Variants
Introduction
Corinna Kern is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptide variants that can cleave fusarium toxins. Her innovative work has the potential to impact various industries, including agriculture and food safety.
Latest Patents
Corinna Kern holds a patent for "Fusarium toxin-cleaving polypeptide variants, additive containing same, use of same, and method for splitting fusarium toxins." This invention relates to toxin-cleaving polypeptide variants of a toxin carboxyl esterase with the SEQ ID NO:46. Each of the polypeptide variants has an amino acid sequence shortened by 47 amino acids at the N terminus, and the amino acid sequences have at least 70%, preferably 80%, and in particular 100%, sequence identity to the amino acid sequence portion 48-540 of the SEQ ID NO:46. The invention also includes isolated polynucleotides that code for the polypeptide variants, an additive containing at least one polypeptide variant, and a method for hydrolytically cleaving at least one toxin.
Career Highlights
Corinna Kern is associated with Erber Aktiengesellschaft, a company known for its focus on innovative solutions in the agricultural sector. Her work at the company has allowed her to explore and develop groundbreaking technologies that address critical challenges in toxin management.
Collaborations
Throughout her career, Corinna has collaborated with notable colleagues, including Markus Aleschko and Dieter Moll. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.
Conclusion
Corinna Kern's contributions to the field of biotechnology, particularly through her patent on toxin-cleaving polypeptide variants, highlight her role as an influential inventor. Her work continues to pave the way for advancements in toxin management and safety in various applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile